Inhibition of human lymphocyte transformation by human. cap alpha. -fetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism
Conference
·
OSTI ID:7291187
To explain the mechanism of inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP), we sought for, and failed to find, evidence of physical association between HAFP and phytomitogens or antihuman thymocyte antiserum. In addition, 20 to 40 fold increases in mitogen dose do not reverse the inhibition of lymphocyte transformation by a constant dose of HAFP. The presence of HAFP does not interfere with the attachment of /sup 125/I-labeled phytohemagglutinin to the lymphocyte surface. Two-dimensional crossed immunoelectrophoresis of HAFP isolated from the body fluids of hepatoma patients demonstrates three charged species of HAFP designated as HAFP-1 (the most cathodal), HAFP-2, and HAFP-3 (the most anodal). The potency of HAFP isolates in inhibiting lymphocyte transformation can be positively correlated with the ratio HAFP-3 : HAFP-1 in each preparation. Passage of HAFP isolates over CM-cellulose allows the isolation of two HAFP fractions, one at pH 4.95, and the other at pH 5.24. The pH 4.95 CM-cellulose isolate is enriched in the more electronegative HAFP species (HAFP-3) and is, on the average, two times more potent than the pH 5.24 CM-cellulose HAFP isolate. The latter, by comparison with native HAFP, is enriched in the more electropositive HAFP species (HAFP-1). The CM-cellulose HAFP isolates are identical in sialic acid content.
- Research Organization:
- Chicago Univ., Ill. (USA). Dept. of Medicine; Franklin McLean Memorial Research Inst., Chicago, Ill. (USA)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 7291187
- Report Number(s):
- CONF-770860-2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants
Inhibition of human lymphocyte transformation by human. cap alpha. -fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation
Postsynthetic modification of human. cap alpha. -fetoprotein controls its immunosuppressive potency
Journal Article
·
Tue Nov 30 23:00:00 EST 1976
· Proc. Natl. Acad. Sci. U.S.A.; (United States)
·
OSTI ID:7227757
Inhibition of human lymphocyte transformation by human. cap alpha. -fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation
Journal Article
·
Mon Aug 01 00:00:00 EDT 1977
· J. Immunol.; (United States)
·
OSTI ID:7316513
Postsynthetic modification of human. cap alpha. -fetoprotein controls its immunosuppressive potency
Journal Article
·
Thu Sep 01 00:00:00 EDT 1977
· Proc. Natl. Acad. Sci. U.S.A.; (United States)
·
OSTI ID:7277186
Related Subjects
550200* -- Biochemistry
59 BASIC BIOLOGICAL SCIENCES
AGGLUTININS
ANIMAL CELLS
BETA DECAY RADIOISOTOPES
BIOCHEMISTRY
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CARBOHYDRATES
CELLULOSE
CHEMISTRY
CONNECTIVE TISSUE CELLS
DAYS LIVING RADIOISOTOPES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
ELECTROPHORESIS
HEMAGGLUTININS
HEPATOMAS
IMMUNE SERUMS
INHIBITION
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE ISOTOPES
ISOTOPES
LEUKOCYTES
LYMPHOCYTES
MUCOPROTEINS
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
PATIENTS
PH VALUE
PHYTOHEMAGGLUTININ
POLYSACCHARIDES
PROTEINS
RADIOISOTOPES
SACCHARIDES
SIALIC ACID
SOMATIC CELLS
59 BASIC BIOLOGICAL SCIENCES
AGGLUTININS
ANIMAL CELLS
BETA DECAY RADIOISOTOPES
BIOCHEMISTRY
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CARBOHYDRATES
CELLULOSE
CHEMISTRY
CONNECTIVE TISSUE CELLS
DAYS LIVING RADIOISOTOPES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
ELECTROPHORESIS
HEMAGGLUTININS
HEPATOMAS
IMMUNE SERUMS
INHIBITION
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE ISOTOPES
ISOTOPES
LEUKOCYTES
LYMPHOCYTES
MUCOPROTEINS
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
PATIENTS
PH VALUE
PHYTOHEMAGGLUTININ
POLYSACCHARIDES
PROTEINS
RADIOISOTOPES
SACCHARIDES
SIALIC ACID
SOMATIC CELLS